Hap Trading, LLC Applied Genetic Technologies Corp Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.1 $1,550 - $2,750	-2,500 Reduced 14.62%	14,600 $0
Q1 2022 May 12, 2022	BUY	$1.07 - $2.71 $18,297 - $46,341	17,100 New	17,100 $2,000
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $30,107 - $46,851	-16,100 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$3.01 - $4.12 $77,959 - $106,708	-25,900 Reduced 61.67%	16,100 $0
Q2 2021 Aug 11, 2021	SELL	$3.62 - $5.23 $51,766 - $74,789	-14,300 Reduced 25.4%	42,000 $4,000
Q1 2021 May 14, 2021	BUY	$3.94 - $8.19 $150,508 - $312,858	38,200 Added 211.05%	56,300 $28,000
Q4 2020 Feb 16, 2021	BUY	$3.99 - $5.7 $13,167 - $18,810	3,300 Added 22.3%	18,100 $3,000
Q3 2020 Nov 13, 2020	BUY	$4.38 - $6.43 $1,752 - $2,572	400 Added 2.78%	14,800 $7,000
Q2 2020 Aug 10, 2020	BUY	$3.0 - $6.9 $43,200 - $99,360	14,400 New	14,400 $10,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.